The China Food and Drug Administration (CFDA) has cleared Elekta’s Versa HD radiation therapy system for sale and marketing in the country.
Versa HD is equipped with the Agility multileaf collimator for high-speed, high-precision beam shaping to support accurate tumor targeting and improved healthy tissue preservation.
Elekta’s Anming Gong, Managing Director for China, says: “As cancer rates continue to rise in China, the need for advanced and effective treatment becomes even greater. Versa HD will help support the government’s health care reform, which includes upgrading community and rural health care facilities by 2020.”
The radiation therapy system has previously been approved in the EU and in the United States.